Human Umbilical Cord Perivascular Cells improve human pancreatic islet transplantation function
Tissue Regeneration Therapeutics’ collaborator the Scottish National Blood Transfusion Services (SNBTS) together with both the University of Edinburgh and the University of Glasgow, publish a major new paper showing Human Umbilical Cord Perivascular Cells improve human pancreatic islet transplant function “The immunosuppressive …
Tissue Regeneration Therapeutics engineered mesenchymal stromal cells advance monoclonal antibody therapy
Toronto, Canada, August 15th 2016: Tissue Regeneration Therapeutics Inc. (TRT) today announced that a team of Canadian researchers have for the first time shown that TRT’s engineered mesenchymal stromal cell product (eTXP) can be used to deliver therapeutically useful monoclonal antibodies (mAbs) …